{"_links": {"parentPackage": {"href": "/mdr/ct/packages/sdtmct-2023-03-31", "title": "SDTM Controlled Terminology Package 53 Effective 2023-03-31", "type": "Terminology"}, "priorVersion": {"href": "/mdr/ct/packages/sdtmct-2022-12-16/codelists/C114118", "title": "CDISC SDTM Protocol Milestone Terminology", "type": "Code List"}, "rootItem": {"href": "/mdr/root/ct/sdtmct/codelists/C114118", "title": "Version-agnostic anchor resource for codelist C114118", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/sdtmct-2023-03-31/codelists/C114118", "title": "CDISC SDTM Protocol Milestone Terminology", "type": "Code List"}}, "conceptId": "C114118", "definition": "A terminology codelist relevant to protocol-specified, point-in-time events during a study.", "extensible": "true", "name": "Protocol Milestone", "preferredTerm": "CDISC SDTM Protocol Milestone Terminology", "submissionValue": "PROTMLST", "synonyms": ["Protocol Milestone"], "terms": [{"conceptId": "C186210", "definition": "An indication that the subject has declined to continue into a subsequent trial Element.", "preferredTerm": "Declined to Continue Into Next Trial Element", "submissionValue": "DECLINED TO CONTINUE INTO NEXT TRIAL ELEMENT"}, {"conceptId": "C176358", "definition": "An indication that the subject has declined to continue into the survival follow-up phase of the trial.", "preferredTerm": "Declined To Continue Into Survival Follow-Up", "submissionValue": "DECLINED TO CONTINUE INTO SURVIVAL FOLLOW-UP"}, {"conceptId": "C132447", "definition": "The subject has fulfilled the criteria needed to enter or continue in the study.", "preferredTerm": "Eligibility Criteria Met By Subject", "submissionValue": "ELIGIBILITY CRITERIA MET"}, {"conceptId": "C161417", "definition": "The subject has met eligibility criteria and is enrolled in the study. The subject may or may not subsequently be randomized.", "preferredTerm": "Subject Entered Into Trial", "submissionValue": "ENTERED INTO TRIAL"}, {"conceptId": "C161418", "definition": "Assent given by a minor or adult who is unable to give informed consent on their own behalf, to participate in a clinical trial. Assent must be accompanied by consent from a parent or legal guardian for full participation in the study.", "preferredTerm": "Informed Assent", "submissionValue": "INFORMED ASSENT OBTAINED", "synonyms": ["Informed Assent"]}, {"conceptId": "C16735", "definition": "Consent given by a subject, or in the case of an individual that can only give assent, by a parent or legal guardian, for the participation in a clinical study only after having achieved an understanding of both the relevant medical facts and the relevant risks involved.", "preferredTerm": "Informed Consent", "submissionValue": "INFORMED CONSENT OBTAINED"}, {"conceptId": "C186211", "definition": "An indication that the subject has opted to continue into a subsequent trial Element.", "preferredTerm": "Opted to Continue Into Next Trial Element", "submissionValue": "OPTED TO CONTINUE INTO NEXT TRIAL ELEMENT"}, {"conceptId": "C176357", "definition": "An indication that the subject has opted to continue into the survival follow-up phase of the trial.", "preferredTerm": "Opted To Continue Into Survival Follow-Up", "submissionValue": "OPTED TO CONTINUE INTO SURVIVAL FOLLOW-UP"}, {"conceptId": "C114209", "definition": "Participants are assigned to arms of a clinical trial by chance.", "preferredTerm": "Subject is Randomized", "submissionValue": "RANDOMIZED"}, {"conceptId": "C186212", "definition": "Participants are re-assigned by chance to arms of a clinical trial.", "preferredTerm": "Re-randomized", "submissionValue": "RE-RANDOMIZED"}]}